Low Dose Azithromycin Prophylaxis in Primary Antibody Deficiencies

C. Milito (Rome, Italy), F. Pulvirenti (Rome, Italy), S. Tabolli (Rome, Italy), M. Carrabba (Milan, Italy), G. Fabio (Milan, Italy), R. Delle Piane (Milan, Italy), M. Pietrogrande (Milan, Italy), F. Cinetto (Padua, Italy), C. Agostini (Padua, Italy), A. Plebani (Brescia, Italy), V. Lougaris (Brescia, Italy), A. Soresina (Brescia, Italy), A. Matucci (Florence, Italy), A. Vultaggio (Florence, Italy), G. Spadaro (Naples, Italy), A. Pecoraro (Naples, Italy), B. Martire (Bari, Italy), I. Quinti (Rome, Italy)

Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Milito (Rome, Italy), F. Pulvirenti (Rome, Italy), S. Tabolli (Rome, Italy), M. Carrabba (Milan, Italy), G. Fabio (Milan, Italy), R. Delle Piane (Milan, Italy), M. Pietrogrande (Milan, Italy), F. Cinetto (Padua, Italy), C. Agostini (Padua, Italy), A. Plebani (Brescia, Italy), V. Lougaris (Brescia, Italy), A. Soresina (Brescia, Italy), A. Matucci (Florence, Italy), A. Vultaggio (Florence, Italy), G. Spadaro (Naples, Italy), A. Pecoraro (Naples, Italy), B. Martire (Bari, Italy), I. Quinti (Rome, Italy). Low Dose Azithromycin Prophylaxis in Primary Antibody Deficiencies. 5100

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Evaluation of Airway Wall Thickness in Severe Asthma with monoclonal antibody therapy
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Prevalence of Latent Infection with Mycobacterium Tuberculosis in Interstitial Lung Diseases Using Interferon Gamma Release Assay
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to  Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019




Half Dose Urokinase Can Be Effective in Patients with Complicated Parapneumonic Effusion.
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017

Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018


Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


The Effect on Chest Tube Drainage of Postoperative Prophylactic Enoxaparin in Patients with Non-small Cell Lung Cancer
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018

Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition
Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Year: 2017

A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018